Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...

Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.

Courts are increasingly confronting AI-generated and AI-manipulated evidence land on their dockets. But with innovation comes ...

LSEG has launched Trade Surveillance, a new service designed to help financial institutions identify and investigate potential market abuse and financial crime more efficiently. Now live with ...

Bechtle AG has strengthened its European PLM presence by acquiring EuroSolid Zrt., Hungary’s largest SOLIDWORKS reseller and a long-standing partner of the local manufacturing industry. Founded in ...